glp-1 gip therapy weight management benefits The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal hormone had the greatest Science Behind GLP 1 GIP

Administering your own shot can feel intimidating, and its tough to replicate the precision and care of a trained professional

Nooms approach to weight loss is grounded in psychology and supported by extensive clinical research

These achieve substantially greater LDL reductions than the modest 17% decreases observed with GLP-1 receptor agonists

B12 deficiency more common than most people realize, particularly in people over 40 and those with certain dietary patterns can significantly impair energy and metabolic function

Consistent Treatment: If your therapy involves multiple sessions, be consistent with your appointments

Interactions CYP: In vivo, one study reported increased or decreased expression of different isoforms (Olsozowy 2006)